BioMedNewsBreaks – HealthLynked Corp. (HLYK) Announces Expansion of Its Telehealth Services Nationwide, New Service

HealthLynked (OTCQB: HLYK), a trailblazer in healthcare technology, today announced a partnership with Lyric Health, a comprehensive virtual care provider. This partnership, which entails integrating HealthLynked with Lyric Health, enables the company to expand its telehealth services nationwide to all 50 states. As part of this expansion, the company has introduced its new Virtual Urgent Care service, which enables members to connect with a licensed physician within an average of 20 minutes. Additionally, HealthLynked intends to launch its Virtual Primary Care service, which will allow users to set future appointments with primary care physicians, establishing ongoing relationships with virtual doctors.

“Our integration with Lyric Health and the launch of our Virtual Urgent Care service is a game-changer for our members. We are now able to offer an unparalleled range of healthcare services to patients nationwide, ensuring that quality care is just a click away, no matter where they are. Our upcoming Virtual Primary Care service will further enhance this experience, providing continuity of care for our members,” said Dr. Michael Dent, CEO of HealthLynked.

To view the full press release, visit https://ibn.fm/uEFdm

About HealthLynked Corp.

HealthLynked Corp. is committed to improving global healthcare by facilitating the efficient exchange of medical information between patients and providers. The company’s network empowers members to actively manage their healthcare through a centralized and secure platform. For more information about HealthLynked Corp., please visit www.healthlynked.com.

NOTE TO INVESTORS: The latest news and updates relating to HealthLynked are available in the company’s newsroom at https://IBN.fm/HLYK

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN